VOYA Investment Management’s Structure Therapeutics GPCR Stock Holding History

VOYA Investment Management’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.38M	Hold	44,410	–	–	﹤0.01%	1159
2026 Q1	$2.14M	Sell	44,410 -10,890	-20%	-$745K	﹤0.01%	1149
2025 Q4	$3.85M	Buy	55,300 +38,875	+237%	+$1.59M	﹤0.01%	970
2025 Q3	$460K	Sell	16,425 -14,230	-46%	-$283K	﹤0.01%	1793
2025 Q2	$636K	Buy	30,655 +4,715	+18%	+$104K	﹤0.01%	1780
2025 Q1	$449K	Hold	25,940	–	–	﹤0.01%	1915
2024 Q4	$703K	Sell	25,940 -20,830	-45%	-$739K	﹤0.01%	1784
2024 Q3	$2.05M	Sell	46,770 -14,940	-24%	-$578K	﹤0.01%	1327
2024 Q2	$2.42M	Buy	+61,710	New	+$2.53M	﹤0.01%	1260
2024 Q1	–	Sell	-9,730	Closed	-$397K	–	2826
2023 Q4	$397K	Sell	9,730 -76,744	-89%	-$4.4M	﹤0.01%	2195
2023 Q3	$4.36M	Buy	+86,474	New	+$2.79M	﹤0.01%	1030

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Jupiter Topco New York $245B AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

VOYA Investment Management's GPCR Position: Q2 2026 in Review

VOYA Investment Management held its Structure Therapeutics (GPCR) position steady in Q2 2026 at 44,410 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1159.

VOYA Investment Management first reported a position in GPCR in Q3 2023 and has held it in 11 quarters since. The position peaked at $4.36M in Q3 2023. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

VOYA Investment Management held 44,410 shares of Structure Therapeutics worth $2.38M as of Q2 2026.
VOYA Investment Management left its Structure Therapeutics share count unchanged in Q2 2026.
Structure Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1159 holding.
VOYA Investment Management first reported a position in Structure Therapeutics in Q3 2023 and has held it in 11 quarters since.
VOYA Investment Management's Structure Therapeutics position peaked at $4.36M in Q3 2023.
191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.